Menu
Back to Journals » Infection and Drug Resistance » Volume 4
Treatment of drug-resistant tuberculosis
Published 21 July 2011 Volume 2011:4 Pages 129—135
DOI https://doi.org/10.2147/IDR.S10332
Review by Single anonymous peer review
Peer reviewer comments 2
Lancelot Pinto1,2, Dick Menzies1,2
1Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, Montreal, QC, Canada; 2Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada
Clinical question: What is the best approach to the treatment of drug-resistant tuberculosis (TB)?
Results: Evidence-based treatment of drug-susceptible TB is the best means of preventing the development of drug-resistant disease. Suspecting the possibility of drug-resistant TB, and prompt detection of all forms of drug-resistant TB, not only multidrug-resistant and extensively drug-resistant TB, should be part of the algorithm for diagnosis and management of all patients with active TB.
Implementation: Treatment of all forms of drug-resistant TB must be tailored to the specific form of resistance with appropriate and effective drug regimens.
Keywords: drug-resistant tuberculosis, MDR-TB, treatment
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.